更正：接受同步化疗和调强放射治疗的肛门癌机构队列患者的治疗结果和人乳头瘤病毒特征
Correction: Treatment outcomes and HPV characteristics for an institutional cohort of patients with anal cancer receiving concurrent chemotherapy and intensity-modulated radiation therapy.
作者信息
Foster Corey C, Lee Andrew Y, Furtado Larissa V, Hart John, Alpert Lindsay, Xiao Shu-Yuan, Hyman Neil H, Sharma Manish R, Liauw Stanley L
出版信息
PLoS One. 2018 Jul 5;13(7):e0200400. doi: 10.1371/journal.pone.0200400. eCollection 2018.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0194234.].
摘要
[本文更正了文章的数字对象标识符：10.1371/journal.pone.0194234。]
相似文献
1
Correction: Treatment outcomes and HPV characteristics for an institutional cohort of patients with anal cancer receiving concurrent chemotherapy and intensity-modulated radiation therapy.更正：接受同步化疗和调强放射治疗的肛门癌机构队列患者的治疗结果和人乳头瘤病毒特征
PLoS One. 2018 Jul 5;13(7):e0200400. doi: 10.1371/journal.pone.0200400. eCollection 2018.
2
Treatment outcomes and HPV characteristics for an institutional cohort of patients with anal cancer receiving concurrent chemotherapy and intensity-modulated radiation therapy.机构队列中接受同期化疗和调强放疗的肛门癌患者的治疗结果和 HPV 特征。
PLoS One. 2018 Mar 9;13(3):e0194234. doi: 10.1371/journal.pone.0194234. eCollection 2018.
3
A multi-institutional acute gastrointestinal toxicity analysis of anal cancer patients treated with concurrent intensity-modulated radiation therapy (IMRT) and chemotherapy.多机构分析同步强度调节放射治疗（IMRT）和化疗治疗肛门癌患者的急性胃肠道毒性。
Radiother Oncol. 2009 Nov;93(2):298-301. doi: 10.1016/j.radonc.2009.07.006. Epub 2009 Aug 28.
4
Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience.肛管癌患者同步化疗与调强放射治疗：多中心经验
J Clin Oncol. 2007 Oct 10;25(29):4581-6. doi: 10.1200/JCO.2007.12.0170.
5
Current treatment for localized anal carcinoma.局限性肛管癌的当前治疗方法。
Curr Opin Oncol. 2007 Jul;19(4):396-400. doi: 10.1097/CCO.0b013e32816f76de.
6
Correction: Self-collected and clinician-collected anal swabs show modest agreement for HPV genotyping.更正：自我采集和临床医生采集的肛门拭子在HPV基因分型方面显示出适度的一致性。
PLoS One. 2023 Jul 7;18(7):e0288418. doi: 10.1371/journal.pone.0288418. eCollection 2023.
7
Concurrent chemotherapy and intensity-modulated radiation therapy for anal carcinoma--clinical outcomes in a large National Cancer Institute-designated integrated cancer centre network.同期化疗和调强放疗治疗肛门癌——大型美国国家癌症研究所指定综合癌症中心网络的临床结果。
Clin Oncol (R Coll Radiol). 2012 Aug;24(6):424-31. doi: 10.1016/j.clon.2011.09.014. Epub 2011 Nov 8.
8
Correction: Genetic Diversity in the Major Capsid L1 Protein of HPV-16 and HPV-18 in the Netherlands.更正：荷兰人乳头瘤病毒16型和18型主要衣壳L1蛋白的遗传多样性
PLoS One. 2016 Apr 28;11(4):e0154977. doi: 10.1371/journal.pone.0154977. eCollection 2016.
9
Correction: Anal cancer in high-income countries: Increasing burden of disease.更正：高收入国家的肛门癌：疾病负担不断增加。
PLoS One. 2019 May 8;14(5):e0216884. doi: 10.1371/journal.pone.0216884. eCollection 2019.
10
Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy.同步放化疗联合调强放疗治疗的肛管癌患者骨髓剂量学参数与急性血液学毒性的相关性
Int J Radiat Oncol Biol Phys. 2008 Apr 1;70(5):1431-7. doi: 10.1016/j.ijrobp.2007.08.074. Epub 2007 Nov 8.
本文引用的文献
1
Treatment outcomes and HPV characteristics for an institutional cohort of patients with anal cancer receiving concurrent chemotherapy and intensity-modulated radiation therapy.机构队列中接受同期化疗和调强放疗的肛门癌患者的治疗结果和 HPV 特征。
PLoS One. 2018 Mar 9;13(3):e0194234. doi: 10.1371/journal.pone.0194234. eCollection 2018.
Zotero 插件